Business ❯Pharmaceutical Industry

Market Trends

Drug Pricing Weight Loss Drugs Drug Development Pricing Strategies Novo Nordisk Sales Performance Drug Competition Consumer Behavior Sales Growth Consumer Genetics Healthcare Costs Obesity Drug Market Drug Adoption Rates Drug Research Celebrity Endorsements Drug Shortages Investment Weight-loss Market CBD Market Weight Loss Drug Market Drug Launches Drug Production Investor Insights Stock Performance Drug Demand Obesity Drugs Market Investor Sentiment Drug Sales

Pfizer Halts Development of Weight-Loss Pill After Liver Injury in Trial

The pharmaceutical giant discontinues danuglipron following safety concerns but shifts focus to alternative obesity treatments in its pipeline.

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

U.S. Obesity Rates Decline for First Time in Over a Decade

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

Reproductive Health Product Sales Surge Post-Trump Election Win

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Supply and Cost Challenges Persist for Popular Weight-Loss Drugs

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations

New Studies Confirm Safety of Semaglutide for Mental Health

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

Compounded Weight Loss Drugs Raise Safety and Ethical Concerns

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Weight-Loss Drugs Reshape Health and Consumer Markets

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

Roche Accelerates Development of Promising Weight-Loss Pills

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

Roche's New Weight Loss Pill Shakes Up Pharmaceutical Market